InvestorsHub Logo
Followers 2
Posts 998
Boards Moderated 0
Alias Born 06/02/2012

Re: None

Monday, 08/13/2018 9:02:48 AM

Monday, August 13, 2018 9:02:48 AM

Post# of 15240
Look what I stumbled across this weekend:

Amgen CAR-T Sub-License

Amgen CAR-T Pre-Clinical Results

While these are just getting started, the scope of the Kite/Amgen agreement appears to be for other treatments. Also, there are a different set of patents covered including a couple from Cell Genesys. Maybe we see something from these and GVAX within the next decade. That's what I call a royalty pipeline.

I think there are some publicly traded companies that are pure royalty plays. We can't get any love here either.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News